Science Explorer Interactive view Map
Company · Toronto · Canada

Helix Biopharma (Canada)

helixbiopharma.comROR OpenAlex
Research works
22
▼ 59% vs 2013–17
Citations
457
21.1 per fractional work
Top-10% rate
4.8%
record average 16.5%
Open access
23%
world 28%

Not ranked overall: Helix Biopharma (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.82× its world share, 0 worksBiochemistry, Geneti…Engineering: 0.36× its world share, 0 worksEngineeringHealth Professions: 10.54× its world share, 1 worksHealth ProfessionsMedicine: 2.05× its world share, 1 worksMedicinePsychology: 2.02× its world share, 0 worksPsychologySocial Sciences: 0.49× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 10.5×. Every wedge is a field page.

Which keywords describe research at Helix Biopharma (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Tumor Targeting, Glycosylation, Tumor Microenvironment, Monoclonal Antibodies, HIF-1 and Warburg Effect.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Immunotherapy2▲ 16×3 topics
  2. Glycosylation2▲ 37×3 topics
  3. Tumor Regression2▲ 96×2 topics
  4. Tumor Targeting2▲ 63×2 topics
  5. Tumor Microenvironment2▲ 21×2 topics
  6. Monoclonal Antibodies2▲ 48×3 topics
  7. HIF-11▲ 88×1 topic
  8. Warburg Effect1▲ 88×1 topic
  9. Arginine Deprivation1▲ 139×1 topic
  10. Bacterial Therapy1▲ 139×1 topic
  11. Cancer1▲ 4.3×6 topics
  12. Therapeutic Antibodies1▲ 48×2 topics
  13. Antibody Engineering1▲ 54×1 topic
  14. Fc Receptors1▲ 54×1 topic
  15. Gene Expression1▲ 9.3×4 topics
  16. Oxidative Stress1▲ 3.0×4 topics
  17. Angiogenesis1▲ 12×4 topics

Which research topics does Helix Biopharma (Canada) publish most on?

By volume in 2022–2025: Family and Patient Care in Intensive Care Units, Disaster Response and Management, Cardiac Arrest and Resuscitation and Cancer, Hypoxia, and Metabolism.

Family and Patient Care in Intensive Care Units: 0 fractional worksDisaster Response and Management: 0 fractional worksCardiac Arrest and Resus…0Cardiac Arrest and Resuscitation: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksChild Development and Di…0Child Development and Digital Technology: 0 fractional worksDigital Mental Health In…0Digital Mental Health Interventions: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksAdolescent and Pediatric Healthcare: 0 fractional works
Radiological and Ultrasound TechnologyEmergency Medical ServicesEmergency MedicineCancer Research6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Family and Patient Care in Intensive Care Units Radiological and Ultrasound Technology 0 works
  2. 2 Disaster Response and Management Emergency Medical Services 0 works
  3. 3 Cardiac Arrest and Resuscitation Emergency Medicine 0 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 Child Development and Digital Technology Education 0 works
  6. 6 Digital Mental Health Interventions Applied Psychology 0 works
  7. 7 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  8. 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Adolescent and Pediatric Healthcare Speech and Hearing 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.6%not open77.4%

World: 28% of research is openly available.

with international co-authors25.1%domestic only74.9%

World: 19% is written across borders.

How has Helix Biopharma (Canada)'s research output changed?

Output in 2018–2022 was 59% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Toronto

All research institutions in Toronto

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.